Mosby's 2014 Nursing Drug Reference (225 page)

BOOK: Mosby's 2014 Nursing Drug Reference
9.98Mb size Format: txt, pdf, ePub

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

isoflurophate
ophthalmic

See
Appendix B

 

isoniazid (Rx)

(eye-soe-nye′a-zid)

Isotamine

Func. class.:
Antitubercular

Chem. class.:
Isonicotinic acid hydrazide

ACTION:

Bactericidal interference with lipid, nucleic acid biosynthesis

USES:

Treatment, prevention of TB

CONTRAINDICATIONS:

Hypersensitivity

 

Black Box Warning:

Acute hepatic disease

Precautions:
Pregnancy (C), renal disease, diabetic retinopathy, cataracts, ocular defects, IV drug users, >35 yr, postpartum, HIV, neuropathy

 

Black Box Warning:

Alcoholism, females (African descent/Hispanic patients)

DOSAGE AND ROUTES
Calculator

• Adult/adolescent with/without HIV: PO/IM
5 mg/kg/day ≤300 mg/day or 15 mg/kg 2-3×/wk, max 900 mg 2-3×/wk

• Child/infant with HIV: PO/IM
10-15 mg/kg/day, max 300 mg/day

Available forms:
Tabs 100, 300 mg; inj 100 mg/ml

Administer:
PO route

• 
PO with meals to decrease GI symptoms; better to take on empty stomach 1 hr before or 2 hr after meals

IM route

• 
IM deep in large muscle mass; massage; rotate inj site; warm inj to room temp to dissolve crystals

SIDE EFFECTS

CNS:
Peripheral neuropathy, dizziness
, memory impairment,
toxic encephalopathy, seizures,
psychosis, slurred speech

EENT:
Blurred vision, optic neuritis

GI:
Nausea, vomiting
, epigastric distress,
jaundice, fatal hepatitis

HEMA:
Agranulocytosis, hemolytic, aplastic anemia, thrombocytopenia, eosinophilia, methemoglobinemia

Hypersensitivity:
Fever, skin eruptions, lymphadenopathy, vasculitis

MISC:
Dyspnea, B
6
deficiency, pellagra, hyperglycemia, metabolic acidosis, gynecomastia, rheumatic syndrome, SLE-like syndrome

PHARMACOKINETICS

Metabolized in liver, excreted in urine (metabolites), crosses placenta, excreted in breast milk, half life 1-4 hr

PO:
Peak 1-2 hr

IM:
Peak 45-60 min

INTERACTIONS

Increase:
toxicity—tyramine foods, alcohol, cycloSERINE, ethionamide, rifampin, carBAMazepine, phenytoin, benzodiazepines, meperidine

Increase:
serotonin syndrome—SSRIs, SNRIs

Decrease:
absorption—aluminum antacids

Decrease:
effectiveness of BCG vaccine, ketoconazole

Drug/Food

• 
Do not give with high-tyramine foods, alcohol

Drug/Lab Test

Increase:
LFTs, bilirubin, glucose

Decrease:
platelets granulocytes

NURSING CONSIDERATIONS
Assess:

 

Black Box Warning:

Hepatic studies weekly: baseline in all patients, those >35 yr and all women should be monitored periodically; ALT, AST, bilirubin; increased test results may indicate hepatitis; hepatic status: decreased appetite, jaundice, dark urine, fatigue, those with fast acetylation (genetic) may metabolize product more than 5 times faster (black, Asian patients are at greater risk) some Caucasian patients; fatal hepatitis is at greater risk in black/Hispanic patients after birth

• 
Mental status often: affect, mood, behavioral changes; psychosis may occur

• 
Paresthesia in hands, feet

Evaluate:

• 
Therapeutic response: decreased symptoms of TB

Teach patient/family:

• 
That compliance with dosage schedule, duration is necessary; not to skip or double dose

• 
That scheduled appointments must be kept or relapse may occur

 
To avoid alcohol while taking product; may increase risk for hepatic injury

• 
That, if diabetic, to use blood glucose monitor to obtain correct result

 
To report weakness, fatigue, loss of appetite, nausea, vomiting, jaundice of skin or eyes, tingling/numbness of hands/feet

 

Black Box Warning:

Fatal hepatitis:
to notify prescriber immediately of yellow skin/eyes, dark urine, loss of appetite

TREATMENT OF OVERDOSE:

Pyridoxine

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

isosorbide dinitrate (Rx)

(eye-soe-sor′bide)

Apo-ISDN
, Dilatrate-SR, Isochron, IsoDitrate, Isordil

isosorbide mononitrate (Rx)

Apo-ISMN
, Imdur

Func. class.:
Antianginal, vasodilator

Chem. class.:
Nitrate

Do not confuse:
Imdur
/Imuran/Inderal/K-Dur

ACTION:

Relaxation of vascular smooth muscle, which leads to decreased preload, afterload, which is responsible for decreasing left ventricular end-diastolic pressure, systemic vascular resistance, and reducing cardiac oxygen demand

USES:

Treatment, prevention of chronic stable angina pectoris

Unlabeled uses:
Diffuse esophageal spasm, heart failure (dinitrate)

CONTRAINDICATIONS:

Hypersensitivity to this product or nitrates; severe anemia, increased intracranial pressure, cerebral hemorrhage, acute MI

Precautions:
Pregnancy (C), breastfeeding, children, postural hypotension, MI, CHF, severe renal/hepatic disease

DOSAGE AND ROUTES
Calculator
Dinitrate

• Adult: PO
5-20 mg bid-tid initially, maintenance 10-40 mg bid-tid;
SL,
buccal 2.5-5 mg, may repeat q5-10min × 3 doses;
EXT REL
40-80 mg q8-12hr, max 160 mg/day

Mononitrate

• Adult: PO
(Monoket) 10-20 mg bid, 7 hr apart; (Imdur) initiate at 30-60 mg/day as a single dose, increase q3days as needed, may increase to 120 mg/day, max 240 mg/day

Available forms:
Dinitrate:
sus rel caps (SR) 40 mg, SR tabs 40 mg; tabs 5, 10, 20, 30, 40 mg; SL tabs 2.5, 5 mg;
mononitrate:
tabs (Monoket) 10, 20 mg; ext rel (Imdur) 30, 60, 120 mg

Administer:

• 
Do not break, crush, or chew sus rel caps, SL tabs

• 
After checking expiration date

• 
PO with 8 oz water on empty stomach

• 
SL tabs should be placed under the tongue until dissolved; avoid smoking, eating, drinking until dissolved

SIDE EFFECTS

CNS:
Vascular headache, flushing, dizziness
, weakness, faintness

CV:
Postural hypotension
, tachycardia,
collapse,
syncope, palpitations

GI:
Nausea, vomiting, diarrhea

INTEG:
Pallor, sweating, rash

MISC:
Twitching,
hemolytic anemia, methemoglobinemia,
tolerance

PHARMACOKINETICS
Dinitrate

Metabolized by liver, excreted in urine as metabolites (80%-100%)

PO:
Onset 15-30 min, duration 4-6 hr, half-life 5-6 hr

SUS REL:
Onset ≤4 hr, duration 6-8 hr

SL:
Onset 2-5 min, duration 1-4 hr, half-life 2 hr

Mononitrate

SUS REL:
Onset 30-60 min, peak 1-4 hr, duration 6-8 hr, half-life 5 hr

INTERACTIONS

 
Fatal hypotension: sildenafil, tadalafil, vardenafil, do not use together

Increase:
hypotension—β-blockers, diuretics, antihypertensives, alcohol, calcium channel blockers, phenothiazines

NURSING CONSIDERATIONS
Assess:

• 
Anginal pain:
duration, time started, activity being performed, character


 
Methemoglobinemia (rare):
Cyanosis of lips, nausea/vomiting, coma, shock, usually caused by high dose of product but may occur with normal dosing

• 
B/P, pulse, respirations during beginning therapy and periodically thereafter

• 
Tolerance if taken over long period, to prevent, allow intervals of 12-14 hr/day without product

• 
Headache, lightheadedness, decreased B/P; may indicate a need for decreased dosage, treat headache with OTC analgesics

Evaluate:

• 
Therapeutic response: decrease or prevention of anginal pain

Teach patient/family:

• 
To leave tabs in original container

• 
To avoid alcohol, OTC products unless approved by prescriber

• 
That product may cause headache; that taking with meals may reduce or eliminate headache; to take no later than 7
PM
(last dose)

• 
To avoid hazardous activities if dizziness occurs

• 
About the importance of complying with complete medical regimen

• 
To make position changes slowly to prevent orthostatic hypotension


 
Not to use with sildenafil, tadalafil, vardenafil with nitrates, may cause serious drop in B/P


 
Not to discontinue abruptly, may cause heart attack


 
To use at beginning of angina symptoms, may repeat every 15 mins; if no relief, seek medical attention immediately

Other books

Scraps of Paper by Griffith, Kathryn Meyer
Stark: A Novel by Bunker, Edward
The Mark of Halam by Thomas Ryan
RoamWild by Valerie Herme´
Humboldt by Emily Brady
The Exiles by Gilbert Morris
No Strings Attached by Kate Angell
To Have (The Dumont Diaries) by Torre, Alessandra
Pohlstars by Frederik Pohl